Global Leucovorin Calcium Injection Market Growth 2020-2025

世界のロイコボリンカルシウム注射市場予測2020-2025:50mg/バイアル、100mg/バイアル、200mg/バイアル、350mg/バイアル

◆タイトル:Global Leucovorin Calcium Injection Market Growth 2020-2025
◆商品コード:LPI20JN09019
◆調査・発行会社:LP Information
◆発行日:2020年6月
◆ページ数:135
◆レポート形式:(印刷可能)PDF / 英語
◆納品方法:Eメール
◆調査対象地域:グローバル、日本、アメリカ、ヨーロッパ、アジア、中国など
◆産業分野:医療、製薬
◆販売価格オプション(消費税別)
Single UserUSD3,660 ⇒換算¥417,240見積依頼/購入/質問フォーム
Multi UserUSD5,490 ⇒換算¥625,860見積依頼/購入/質問フォーム
Corporate UserUSD7,320 ⇒換算¥834,480見積依頼/購入/質問フォーム
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※Eメールによる納品の場合、通常2日~3日以内に納品致します。
※商品の納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はLP Informationの日本における正規販売代理店です。

【レポートの概要】

「ロイコボリンカルシウム注射の世界市場」は、地域的には米州、アジア、欧州、中東・アフリカ市場をカバーしており、種類別には、50mg/バイアル、100mg/バイアル、200mg/バイアル、350mg/バイアルなど、用途別には、病院、クリニック、回復センターなどに区分してまとめた調査レポートです。ロイコボリンカルシウム注射のグローバル市場規模、主要地域・主要国別、種類別、用途別の市場予測、主要企業の概要・市場シェア・販売量、市場動向などの情報が含まれています。
・ロイコボリンカルシウム注射の世界市場概要(サマリー)
・ロイコボリンカルシウム注射の企業別販売量・売上
・ロイコボリンカルシウム注射の企業別市場シェア
・ロイコボリンカルシウム注射の世界市場規模 2015年-2020年:種類別(50mg/バイアル、100mg/バイアル、200mg/バイアル、350mg/バイアル)
・ロイコボリンカルシウム注射の世界市場規模 2015年-2020年:用途別(病院、クリニック、回復センター)
・ロイコボリンカルシウム注射の米州市場規模(アメリカ、カナダ、メキシコなど)
・ロイコボリンカルシウム注射のアジア市場規模(日本、中国、韓国、インド、東南アジアなど)
・ロイコボリンカルシウム注射の欧州市場規模(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ロイコボリンカルシウム注射の中東・アフリカ市場(エジプト、南アフリカ、トルコ、GCC諸国など)
・ロイコボリンカルシウム注射市場の成長要因・課題・動向
・ロイコボリンカルシウム注射の世界市場予測 2021年-2025年
・ロイコボリンカルシウム注射の米州市場予測(アメリカ、カナダ、メキシコなど)
・ロイコボリンカルシウム注射のアジア市場予測(日本、中国、韓国、インド、東南アジアなど)
・ロイコボリンカルシウム注射の欧州市場予測(ドイツ、フランス、イギリス、イタリア、ロシアなど)
・ロイコボリンカルシウム注射の中東・アフリカ市場予測(エジプト、南アフリカ、トルコ、GCC諸国など)
・ロイコボリンカルシウム注射の世界市場予測:種類別(50mg/バイアル、100mg/バイアル、200mg/バイアル、350mg/バイアル)
・ロイコボリンカルシウム注射の世界市場予測:用途別(病院、クリニック、回復センター)
・主要企業分析

COVID-19, the disease it causes, surfaced in late 2019, and now had become a full-blown crisis worldwide. Over fifty key countries had declared a national emergency to combat coronavirus. With cases spreading, and the epicentre of the outbreak shifting to Europe, North America, India and Latin America, life in these regions has been upended the way it had been in Asia earlier in the developing crisis. As the coronavirus pandemic has worsened, the entertainment industry has been upended along with most every other facet of life. As experts work toward a better understanding, the world shudders in fear of the unknown, a worry that has rocked global financial markets, leading to daily volatility in the U.S. stock markets.

According to this latest study, the 2020 growth of Leucovorin Calcium Injection will have significant change from previous year. By the most conservative estimates of global Leucovorin Calcium Injection market size (most likely outcome) will be a year-over-year revenue growth rate of XX% in 2020, from US$ xx million in 2019. We give this scenario a XX% probability, where under the scenario the supply chain will start to recover and quarantines and travel bans will ease, over the Q2. Longer-term, the effect of COVID-19 will be felt throughout the year with some degree of harm done by the virus. Over the next five years the Leucovorin Calcium Injection market will register a XX% CAGR in terms of revenue, the global market size will reach US$ XX million by 2025.

This report presents a comprehensive overview, market shares, and growth opportunities of Leucovorin Calcium Injection market by product type, application, key manufacturers and key regions and countries.

This study specially analyses the impact of Covid-19 outbreak on the Leucovorin Calcium Injection, covering the supply chain analysis, impact assessment to the Leucovorin Calcium Injection market size growth rate in several scenarios, and the measures to be undertaken by Leucovorin Calcium Injection companies in response to the COVID-19 epidemic.

Segmentation by type: breakdown data from 2015 to 2020, in Section 2.3; and forecast to 2025 in section 11.7.
50mg/vial
100mg/vial
200mg/vial
350mg/vial

Segmentation by application: breakdown data from 2015 to 2020, in Section 2.4; and forecast to 2024 in section 11.8.
Hospital
Clinics
Recovery Center

This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Hikma
Sagent
Fresenius Kabi
Teva
Mylan
BluePoint Laboratories
Get Well Pharmaceutical
RMPL Pharma

In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.

Research objectives
To study and analyze the global Leucovorin Calcium Injection consumption (value & volume) by key regions/countries, type and application, history data from 2015 to 2019, and forecast to 2025.
To understand the structure of Leucovorin Calcium Injection market by identifying its various subsegments.
Focuses on the key global Leucovorin Calcium Injection manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Leucovorin Calcium Injection with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Leucovorin Calcium Injection submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

【レポートの目次】

1 Scope of the Report
1.1 Market Introduction
1.2 Research Objectives
1.3 Years Considered
1.4 Market Research Methodology
1.5 Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 What is the Impact of Covid-19 Outbreak On the Leucovorin Calcium Injection?
1.8.1 Optimistic Scenario: COVID-19 Is Contained by May or June, with Normalcy Returning to Global Operations Through the End of Q2.
1.8.2 Conservative Scenario: COVID-19 Remains Prevalent, with Continued Impacts Lasting Into Q4.
1.8.3 Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Leucovorin Calcium Injection Market Size in 2020, by Scenario
1.8.4 Corporate Strategy the Manufacturers Should Be Thinking About Right Now

2 Executive Summary
2.1 World Market Overview
2.1.1 Global Leucovorin Calcium Injection Consumption 2015-2025
2.1.2 Leucovorin Calcium Injection Consumption CAGR by Region
2.2 Leucovorin Calcium Injection Segment by Type
2.2.1 50mg/vial
2.2.2 100mg/vial
2.2.3 200mg/vial
2.2.4 350mg/vial
2.3 Leucovorin Calcium Injection Consumption by Type
2.3.1 Global Leucovorin Calcium Injection Consumption Market Share by Type (2015-2020)
2.3.2 Global Leucovorin Calcium Injection Revenue and Market Share by Type (2015-2020)
2.3.3 Global Leucovorin Calcium Injection Sale Price by Type (2015-2020)
2.4 Leucovorin Calcium Injection Segment by Application
2.4.1 Hospital
2.4.2 Clinics
2.4.3 Recovery Center
2.5 Leucovorin Calcium Injection Consumption by Application
2.5.1 Global Leucovorin Calcium Injection Consumption Market Share by Type (2015-2020)
2.5.2 Global Leucovorin Calcium Injection Value and Market Share by Type (2015-2020)
2.5.3 Global Leucovorin Calcium Injection Sale Price by Type (2015-2020)

3 Global Leucovorin Calcium Injection by Company
3.1 Global Leucovorin Calcium Injection Sales Market Share by Company
3.1.1 Global Leucovorin Calcium Injection Sales by Company (2018-2020)
3.1.2 Global Leucovorin Calcium Injection Sales Market Share by Company (2018-2020)
3.2 Global Leucovorin Calcium Injection Revenue Market Share by Company
3.2.1 Global Leucovorin Calcium Injection Revenue by Company (2018-2020)
3.2.2 Global Leucovorin Calcium Injection Revenue Market Share by Company (2018-2020)
3.3 Global Leucovorin Calcium Injection Sale Price by Company
3.4 Global Leucovorin Calcium Injection Manufacturing Base Distribution, Sales Area, Type by Company
3.4.1 Global Leucovorin Calcium Injection Manufacturing Base Distribution and Sales Area by Company
3.4.2 Players Leucovorin Calcium Injection Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2018-2020)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 Leucovorin Calcium Injection by Regions
4.1 Leucovorin Calcium Injection by Regions
4.2 Americas Leucovorin Calcium Injection Consumption Growth
4.3 APAC Leucovorin Calcium Injection Consumption Growth
4.4 Europe Leucovorin Calcium Injection Consumption Growth
4.5 Middle East & Africa Leucovorin Calcium Injection Consumption Growth

5 Americas
5.1 Americas Leucovorin Calcium Injection Consumption by Countries
5.1.1 Americas Leucovorin Calcium Injection Consumption by Countries (2015-2020)
5.1.2 Americas Leucovorin Calcium Injection Value by Countries (2015-2020)
5.2 Americas Leucovorin Calcium Injection Consumption by Type
5.3 Americas Leucovorin Calcium Injection Consumption by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
5.8 Key Economic Indicators of Few Americas Countries

6 APAC
6.1 APAC Leucovorin Calcium Injection Consumption by Regions
6.1.1 APAC Leucovorin Calcium Injection Consumption by Regions (2015-2020)
6.1.2 APAC Leucovorin Calcium Injection Value by Regions (2015-2020)
6.2 APAC Leucovorin Calcium Injection Consumption by Type
6.3 APAC Leucovorin Calcium Injection Consumption by Application
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 Key Economic Indicators of Few APAC Regions

7 Europe
7.1 Europe Leucovorin Calcium Injection by Countries
7.1.1 Europe Leucovorin Calcium Injection Consumption by Countries (2015-2020)
7.1.2 Europe Leucovorin Calcium Injection Value by Countries (2015-2020)
7.2 Europe Leucovorin Calcium Injection Consumption by Type
7.3 Europe Leucovorin Calcium Injection Consumption by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
7.9 Key Economic Indicators of Few Europe Countries

8 Middle East & Africa
8.1 Middle East & Africa Leucovorin Calcium Injection by Countries
8.1.1 Middle East & Africa Leucovorin Calcium Injection Consumption by Countries (2015-2020)
8.1.2 Middle East & Africa Leucovorin Calcium Injection Value by Countries (2015-2020)
8.2 Middle East & Africa Leucovorin Calcium Injection Consumption by Type
8.3 Middle East & Africa Leucovorin Calcium Injection Consumption by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 Market Drivers, Challenges and Trends
9.1 Market Drivers and Impact
9.1.1 Growing Demand from Key Regions
9.1.2 Growing Demand from Key Applications and Potential Industries
9.2 Market Challenges and Impact
9.3 Market Trends

10 Marketing, Distributors and Customer
10.1 Sales Channel
10.1.1 Direct Channels
10.1.2 Indirect Channels
10.2 Leucovorin Calcium Injection Distributors
10.3 Leucovorin Calcium Injection Customer

11 Global Leucovorin Calcium Injection Market Forecast
11.1 Global Leucovorin Calcium Injection Consumption Forecast (2021-2025)
11.2 Global Leucovorin Calcium Injection Forecast by Regions
11.2.1 Global Leucovorin Calcium Injection Forecast by Regions (2021-2025)
11.2.2 Global Leucovorin Calcium Injection Value Forecast by Regions (2021-2025)
11.2.3 Americas Consumption Forecast
11.2.4 APAC Consumption Forecast
11.2.5 Europe Consumption Forecast
11.2.6 Middle East & Africa Consumption Forecast
11.3 Americas Forecast by Countries
11.3.1 United States Market Forecast
11.3.2 Canada Market Forecast
11.3.3 Mexico Market Forecast
11.3.4 Brazil Market Forecast
11.4 APAC Forecast by Countries
11.4.1 China Market Forecast
11.4.2 Japan Market Forecast
11.4.3 Korea Market Forecast
11.4.4 Southeast Asia Market Forecast
11.4.5 India Market Forecast
11.4.6 Australia Market Forecast
11.5 Europe Forecast by Countries
11.5.1 Germany Market Forecast
11.5.2 France Market Forecast
11.5.3 UK Market Forecast
11.5.4 Italy Market Forecast
11.5.5 Russia Market Forecast
11.6 Middle East & Africa Forecast by Countries
11.6.1 Egypt Market Forecast
11.6.2 South Africa Market Forecast
11.6.3 Israel Market Forecast
11.6.4 Turkey Market Forecast
11.6.5 GCC Countries Market Forecast
11.7 Global Leucovorin Calcium Injection Forecast by Type
11.8 Global Leucovorin Calcium Injection Forecast by Application

12 Key Players Analysis
12.1 Hikma
12.1.1 Company Information
12.1.2 Leucovorin Calcium Injection Product Offered
12.1.3 Hikma Leucovorin Calcium Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.1.4 Main Business Overview
12.1.5 Hikma Latest Developments
12.2 Sagent
12.2.1 Company Information
12.2.2 Leucovorin Calcium Injection Product Offered
12.2.3 Sagent Leucovorin Calcium Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.2.4 Main Business Overview
12.2.5 Sagent Latest Developments
12.3 Fresenius Kabi
12.3.1 Company Information
12.3.2 Leucovorin Calcium Injection Product Offered
12.3.3 Fresenius Kabi Leucovorin Calcium Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.3.4 Main Business Overview
12.3.5 Fresenius Kabi Latest Developments
12.4 Teva
12.4.1 Company Information
12.4.2 Leucovorin Calcium Injection Product Offered
12.4.3 Teva Leucovorin Calcium Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.4.4 Main Business Overview
12.4.5 Teva Latest Developments
12.5 Mylan
12.5.1 Company Information
12.5.2 Leucovorin Calcium Injection Product Offered
12.5.3 Mylan Leucovorin Calcium Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.5.4 Main Business Overview
12.5.5 Mylan Latest Developments
12.6 BluePoint Laboratories
12.6.1 Company Information
12.6.2 Leucovorin Calcium Injection Product Offered
12.6.3 BluePoint Laboratories Leucovorin Calcium Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.6.4 Main Business Overview
12.6.5 BluePoint Laboratories Latest Developments
12.7 Get Well Pharmaceutical
12.7.1 Company Information
12.7.2 Leucovorin Calcium Injection Product Offered
12.7.3 Get Well Pharmaceutical Leucovorin Calcium Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.7.4 Main Business Overview
12.7.5 Get Well Pharmaceutical Latest Developments
12.8 RMPL Pharma
12.8.1 Company Information
12.8.2 Leucovorin Calcium Injection Product Offered
12.8.3 RMPL Pharma Leucovorin Calcium Injection Sales, Revenue, Price and Gross Margin (2018-2020)
12.8.4 Main Business Overview
12.8.5 RMPL Pharma Latest Developments

13 Research Findings and Conclusion

List of Tables
Table 1. Estimated Impact of the Coronavirus (COVID-19) Epidemic on the Global Leucovorin Calcium Injection Market Size in 2020, by Scenario
Table 2. COVID-19: Measures to be Undertaken by Leucovorin Calcium Injection Companies
Table 3. Research Methodology
Table 4. Data Source
Table 5. Leucovorin Calcium Injection Consumption CAGR by Region 2015-2025 ($ Millions)
Table 6. Major Players of 50mg/vial
Table 7. Major Players of 100mg/vial
Table 8. Major Players of 200mg/vial
Table 9. Major Players of 350mg/vial
Table 10. Global Consumption Sales by Type (2015-2020)
Table 11. Global Leucovorin Calcium Injection Consumption Market Share by Type (2015-2020)
Table 12. Global Leucovorin Calcium Injection Revenue by Type (2015-2020) ($ million)
Table 13. Global Leucovorin Calcium Injection Value Market Share by Type (2015-2020) ($ Millions)
Table 14. Global Leucovorin Calcium Injection Sale Price by Type (2015-2020)
Table 15. Global Consumption Sales by Application (2015-2020)
Table 16. Global Leucovorin Calcium Injection Consumption Market Share by Application (2015-2020)
Table 17. Global Leucovorin Calcium Injection Value by Application (2015-2020)
Table 18. Global Leucovorin Calcium Injection Value Market Share by Application (2015-2020)
Table 19. Global Leucovorin Calcium Injection Sale Price by Application (2015-2020)
Table 20. Global Leucovorin Calcium Injection Sales by Company (2017-2019) (K Units)
Table 21. Global Leucovorin Calcium Injection Sales Market Share by Company (2017-2019)
Table 22. Global Leucovorin Calcium Injection Revenue by Company (2017-2019) ($ Millions)
Table 23. Global Leucovorin Calcium Injection Revenue Market Share by Company (2017-2019)
Table 24. Global Leucovorin Calcium Injection Sale Price by Company (2017-2019)
Table 25. Global Leucovorin Calcium Injection Manufacturing Base Distribution and Sales Area by Manufacturers
Table 26. Players Leucovorin Calcium Injection Products Offered
Table 27. Leucovorin Calcium Injection Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
Table 28. Global Leucovorin Calcium Injection Consumption by Regions 2015-2020 (K Units)
Table 29. Global Leucovorin Calcium Injection Consumption Market Share by Regions 2015-2020
Table 30. Global Leucovorin Calcium Injection Value by Regions 2015-2020 ($ Millions)
Table 31. Global Leucovorin Calcium Injection Value Market Share by Regions 2015-2020
Table 32. Americas Leucovorin Calcium Injection Consumption by Countries (2015-2020) (K Units)
Table 33. Americas Leucovorin Calcium Injection Consumption Market Share by Countries (2015-2020)
Table 34. Americas Leucovorin Calcium Injection Value by Countries (2015-2020) ($ Millions)
Table 35. Americas Leucovorin Calcium Injection Value Market Share by Countries (2015-2020)
Table 36. Americas Leucovorin Calcium Injection Consumption by Type (2015-2020) (K Units)
Table 37. Americas Leucovorin Calcium Injection Consumption Market Share by Type (2015-2020)
Table 38. Americas Leucovorin Calcium Injection Consumption by Application (2015-2020) (K Units)
Table 39. Americas Leucovorin Calcium Injection Consumption Market Share by Application (2015-2020)
Table 40. APAC Leucovorin Calcium Injection Consumption by Countries (2015-2020) (K Units)
Table 41. APAC Leucovorin Calcium Injection Consumption Market Share by Countries (2015-2020)
Table 42. APAC Leucovorin Calcium Injection Value by Regions (2015-2020) ($ Millions)
Table 43. APAC Leucovorin Calcium Injection Value Market Share by Regions (2015-2020)
Table 44. APAC Leucovorin Calcium Injection Consumption by Type (2015-2020) (K Units)
Table 45. APAC Leucovorin Calcium Injection Consumption Market Share by Type (2015-2020)
Table 46. APAC Leucovorin Calcium Injection Consumption by Application (2015-2020) (K Units)
Table 47. APAC Leucovorin Calcium Injection Consumption Market Share by Application (2015-2020)
Table 48. Europe Leucovorin Calcium Injection Consumption by Countries (2015-2020) (K Units)
Table 49. Europe Leucovorin Calcium Injection Consumption Market Share by Countries (2015-2020)
Table 50. Europe Leucovorin Calcium Injection Value by Countries (2015-2020) ($ Millions)
Table 51. Europe Leucovorin Calcium Injection Value Market Share by Countries (2015-2020)
Table 52. Europe Leucovorin Calcium Injection Consumption by Type (2015-2020) (K Units)
Table 53. Europe Leucovorin Calcium Injection Consumption Market Share by Type (2015-2020)
Table 54. Europe Leucovorin Calcium Injection Consumption by Application (2015-2020) (K Units)
Table 55. Europe Leucovorin Calcium Injection Consumption Market Share by Application (2015-2020)
Table 56. Middle East & Africa Leucovorin Calcium Injection Consumption by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Leucovorin Calcium Injection Consumption Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Leucovorin Calcium Injection Value by Countries (2015-2020) ($ Millions)
Table 59. Middle East & Africa Leucovorin Calcium Injection Value Market Share by Countries (2015-2020)
Table 60. Middle East & Africa Leucovorin Calcium Injection Consumption by Type (2015-2020) (K Units)
Table 61. Middle East & Africa Leucovorin Calcium Injection Consumption Market Share by Type (2015-2020)
Table 62. Middle East & Africa Leucovorin Calcium Injection Consumption by Application (2015-2020) (K Units)
Table 63. Middle East & Africa Leucovorin Calcium Injection Consumption Market Share by Application (2015-2020)
Table 64. Leucovorin Calcium Injection Distributors List
Table 65. Leucovorin Calcium Injection Customer List
Table 66. Global Leucovorin Calcium Injection Consumption Forecast by Countries (2021-2025) (K Units)
Table 67. Global Leucovorin Calcium Injection Consumption Market Forecast by Regions
Table 68. Global Leucovorin Calcium Injection Value Forecast by Countries (2021-2025) ($ Millions)
Table 69. Global Leucovorin Calcium Injection Value Market Share Forecast by Regions
Table 70. Global Leucovorin Calcium Injection Consumption Forecast by Type (2021-2025) (K Units)
Table 71. Global Leucovorin Calcium Injection Consumption Market Share Forecast by Type (2021-2025)
Table 72. Global Leucovorin Calcium Injection Value Forecast by Type (2021-2025) ($ Millions)
Table 73. Global Leucovorin Calcium Injection Value Market Share Forecast by Type (2021-2025)
Table 74. Global Leucovorin Calcium Injection Consumption Forecast by Application (2021-2025) (K Units)
Table 75. Global Leucovorin Calcium Injection Consumption Market Share Forecast by Application (2021-2025)
Table 76. Global Leucovorin Calcium Injection Value Forecast by Application (2021-2025) ($ Millions)
Table 77. Global Leucovorin Calcium Injection Value Market Share Forecast by Application (2021-2025)
Table 78. Hikma Product Offered
Table 79. Hikma Leucovorin Calcium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 80. Hikma Main Business
Table 81. Hikma Latest Developments
Table 82. Hikma Basic Information, Company Total Revenue (in $ million), Leucovorin Calcium Injection Manufacturing Base, Sales Area and Its Competitors
Table 83. Sagent Product Offered
Table 84. Sagent Leucovorin Calcium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 85. Sagent Main Business
Table 86. Sagent Latest Developments
Table 87. Sagent Basic Information, Company Total Revenue (in $ million), Leucovorin Calcium Injection Manufacturing Base, Sales Area and Its Competitors
Table 88. Fresenius Kabi Product Offered
Table 89. Fresenius Kabi Leucovorin Calcium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 90. Fresenius Kabi Main Business
Table 91. Fresenius Kabi Latest Developments
Table 92. Fresenius Kabi Basic Information, Company Total Revenue (in $ million), Leucovorin Calcium Injection Manufacturing Base, Sales Area and Its Competitors
Table 93. Teva Product Offered
Table 94. Teva Leucovorin Calcium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 95. Teva Main Business
Table 96. Teva Latest Developments
Table 97. Teva Basic Information, Company Total Revenue (in $ million), Leucovorin Calcium Injection Manufacturing Base, Sales Area and Its Competitors
Table 98. Mylan Product Offered
Table 99. Mylan Leucovorin Calcium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 100. Mylan Main Business
Table 101. Mylan Latest Developments
Table 102. Mylan Basic Information, Company Total Revenue (in $ million), Leucovorin Calcium Injection Manufacturing Base, Sales Area and Its Competitors
Table 103. BluePoint Laboratories Product Offered
Table 104. BluePoint Laboratories Leucovorin Calcium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 105. BluePoint Laboratories Main Business
Table 106. BluePoint Laboratories Latest Developments
Table 107. BluePoint Laboratories Basic Information, Company Total Revenue (in $ million), Leucovorin Calcium Injection Manufacturing Base, Sales Area and Its Competitors
Table 108. Get Well Pharmaceutical Product Offered
Table 109. Get Well Pharmaceutical Basic Information, Company Total Revenue (in $ million), Leucovorin Calcium Injection Manufacturing Base, Sales Area and Its Competitors
Table 110. Get Well Pharmaceutical Main Business
Table 111. Get Well Pharmaceutical Latest Developments
Table 112. Get Well Pharmaceutical Leucovorin Calcium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 113. RMPL Pharma Product Offered
Table 114. RMPL Pharma Leucovorin Calcium Injection Sales (K Units), Revenue ($ Million), Price (US$/Unit) and Gross Margin (2018-2020E)
Table 115. RMPL Pharma Main Business
Table 116. RMPL Pharma Latest Developments
Table 117. RMPL Pharma Basic Information, Company Total Revenue (in $ million), Leucovorin Calcium Injection Manufacturing Base, Sales Area and Its Competitors
List of Figures
Figure 1. Picture of Leucovorin Calcium Injection
Figure 2. Leucovorin Calcium Injection Report Years Considered
Figure 3. Market Research Methodology
Figure 4. Global Leucovorin Calcium Injection Consumption Growth Rate 2015-2025 (K Units)
Figure 5. Global Leucovorin Calcium Injection Value Growth Rate 2015-2025 ($ Millions)
Figure 6. Product Picture of 50mg/vial
Figure 7. Product Picture of 100mg/vial
Figure 8. Product Picture of 200mg/vial
Figure 9. Product Picture of 350mg/vial
Figure 10. Global Leucovorin Calcium Injection Consumption Market Share by Type (2015-2020)
Figure 11. Global Leucovorin Calcium Injection Value Market Share by Type (2015-2020)
Figure 12. Leucovorin Calcium Injection Consumed in Hospital
Figure 13. Global Leucovorin Calcium Injection Market: Hospital (2015-2020) (K Units)
Figure 14. Global Leucovorin Calcium Injection Market: Hospital (2015-2020) ($ Millions)
Figure 15. Leucovorin Calcium Injection Consumed in Clinics
Figure 16. Global Leucovorin Calcium Injection Market: Clinics (2015-2020) (K Units)
Figure 17. Global Leucovorin Calcium Injection Market: Clinics (2015-2020) ($ Millions)
Figure 18. Leucovorin Calcium Injection Consumed in Recovery Center
Figure 19. Global Leucovorin Calcium Injection Market: Recovery Center (2015-2020) (K Units)
Figure 20. Global Leucovorin Calcium Injection Market: Recovery Center (2015-2020) ($ Millions)
Figure 21. Global Leucovorin Calcium Injection Consumption Market Share by Application (2015-2020)
Figure 22. Global Leucovorin Calcium Injection Value Market Share by Application (2015-2020)
Figure 23. Global Leucovorin Calcium Injection Sales Market Share by Company in 2017
Figure 24. Global Leucovorin Calcium Injection Sales Market Share by Company in 2019
Figure 25. Global Leucovorin Calcium Injection Revenue Market Share by Company in 2017
Figure 26. Global Leucovorin Calcium Injection Revenue Market Share by Company in 2019
Figure 27. Global Leucovorin Calcium Injection Sale Price by Company in 2019
Figure 28. Global Leucovorin Calcium Injection Consumption Market Share by Regions 2015-2020
Figure 29. Global Leucovorin Calcium Injection Value Market Share by Regions 2015-2020
Figure 30. Americas Leucovorin Calcium Injection Consumption 2015-2020 (K Units)
Figure 31. Americas Leucovorin Calcium Injection Value 2015-2020 ($ Millions)
Figure 32. APAC Leucovorin Calcium Injection Consumption 2015-2020 (K Units)
Figure 33. APAC Leucovorin Calcium Injection Value 2015-2020 ($ Millions)
Figure 34. Europe Leucovorin Calcium Injection Consumption 2015-2020 (K Units)
Figure 35. Europe Leucovorin Calcium Injection Value 2015-2020 ($ Millions)
Figure 36. Middle East & Africa Leucovorin Calcium Injection Consumption 2015-2020 (K Units)
Figure 37. Middle East & Africa Leucovorin Calcium Injection Value 2015-2020 ($ Millions)
Figure 38. Americas Leucovorin Calcium Injection Consumption Market Share by Countries in 2019
Figure 39. Americas Leucovorin Calcium Injection Value Market Share by Countries in 2019
Figure 40. Americas Leucovorin Calcium Injection Consumption Market Share by Type in 2019
Figure 41. Americas Leucovorin Calcium Injection Consumption Market Share by Application in 2019
Figure 42. United States Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 43. United States Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 44. Canada Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 45. Canada Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 46. Mexico Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 47. Mexico Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 48. APAC Leucovorin Calcium Injection Consumption Market Share by Countries in 2019
Figure 49. APAC Leucovorin Calcium Injection Value Market Share by Regions in 2019
Figure 50. APAC Leucovorin Calcium Injection Consumption Market Share by Type in 2019
Figure 51. APAC Leucovorin Calcium Injection Consumption Market Share by Application in 2019
Figure 52. China Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 53. China Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 54. Japan Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 55. Japan Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 56. Korea Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 57. Korea Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 58. Southeast Asia Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 59. Southeast Asia Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 60. India Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 61. India Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 62. Australia Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 63. Australia Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 64. Europe Leucovorin Calcium Injection Consumption Market Share by Countries in 2019
Figure 65. Europe Leucovorin Calcium Injection Value Market Share by Countries in 2019
Figure 66. Europe Leucovorin Calcium Injection Consumption Market Share by Type in 2019
Figure 67. Europe Leucovorin Calcium Injection Consumption Market Share by Application in 2019
Figure 68. Germany Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 69. Germany Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 70. France Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 71. France Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 72. UK Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 73. UK Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 74. Italy Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 75. Italy Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 76. Russia Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 77. Russia Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 78. Middle East & Africa Leucovorin Calcium Injection Consumption Market Share by Countries in 2019
Figure 79. Middle East & Africa Leucovorin Calcium Injection Value Market Share by Countries in 2019
Figure 80. Middle East & Africa Leucovorin Calcium Injection Consumption Market Share by Type in 2019
Figure 81. Middle East & Africa Leucovorin Calcium Injection Consumption Market Share by Application in 2019
Figure 82. Egypt Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 83. Egypt Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 84. South Africa Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 85. South Africa Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 86. Israel Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 87. Israel Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 88. Turkey Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 89. Turkey Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 90. GCC Countries Leucovorin Calcium Injection Consumption Growth 2015-2020 (K Units)
Figure 91. GCC Countries Leucovorin Calcium Injection Value Growth 2015-2020 ($ Millions)
Figure 92. Global Leucovorin Calcium Injection Consumption Growth Rate Forecast (2021-2025) (K Units)
Figure 93. Global Leucovorin Calcium Injection Value Growth Rate Forecast (2021-2025) ($ Millions)
Figure 94. Americas Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 95. Americas Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 96. APAC Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 97. APAC Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 98. Europe Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 99. Europe Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 100. Middle East & Africa Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 101. Middle East & Africa Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 102. United States Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 103. United States Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 104. Canada Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 105. Canada Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 106. Mexico Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 107. Mexico Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 108. Brazil Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 109. Brazil Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 110. China Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 111. China Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 112. Japan Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 113. Japan Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 114. Korea Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 115. Korea Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 116. Southeast Asia Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 117. Southeast Asia Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 118. India Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 119. India Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 120. Australia Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 121. Australia Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 122. Germany Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 123. Germany Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 124. France Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 125. France Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 126. UK Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 127. UK Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 128. Italy Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 129. Italy Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 130. Russia Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 131. Russia Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 132. Spain Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 133. Spain Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 134. Egypt Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 135. Egypt Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 136. South Africa Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 137. South Africa Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 138. Israel Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 139. Israel Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 140. Turkey Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 141. Turkey Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 142. GCC Countries Leucovorin Calcium Injection Consumption 2021-2025 (K Units)
Figure 143. GCC Countries Leucovorin Calcium Injection Value 2021-2025 ($ Millions)
Figure 144. Hikma Leucovorin Calcium Injection Market Share (2018-2020)
Figure 145. Sagent Leucovorin Calcium Injection Market Share (2018-2020)
Figure 146. Fresenius Kabi Leucovorin Calcium Injection Market Share (2018-2020)
Figure 147. Teva Leucovorin Calcium Injection Market Share (2018-2020)
Figure 148. Mylan Leucovorin Calcium Injection Market Share (2018-2020)
Figure 149. BluePoint Laboratories Leucovorin Calcium Injection Market Share (2018-2020)
Figure 150. Get Well Pharmaceutical Leucovorin Calcium Injection Market Share (2018-2020)
Figure 151. RMPL Pharma Leucovorin Calcium Injection Market Share (2018-2020)


【免責事項】
※当レポート上の情報/データは調査会社が信頼できると判断した情報源から入手したものに基づき作成しましたが、その正確性・完全性を保証するものではありません。当レポートに記載された情報/データ/見解/仮説などは作成時点又は発行時点における調査会社の判断であり、その後の状況変化に応じて変更される場合があります。当レポート上の情報/データに基づいたお客様の意思決定又は実行による結果について、調査会社/発行会社/販売会社H&Iグローバルリサーチはその責を負いかねますのでご了承ください。英文資料の紹介ページにおける日本語題名/概要/目次はH&Iグローバルリサーチが翻訳した内容であり、翻訳の正確性・完全性を保証するものではありません。

[世界のロイコボリンカルシウム注射市場予測2020-2025:50mg/バイアル、100mg/バイアル、200mg/バイアル、350mg/バイアル] (Global Leucovorin Calcium Injection Market Growth 2020-2025 / LPI20JN09019)についてメールでお問い合わせはこちら


◆H&Iグローバルリサーチ株式会社のお客様(例)◆